Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
In reporting their case-control study with 245 incident hip
fractures, Pierfitte et al conclude that use of benzodiazepines does not confer any added risk.1 Unusually, plasma
benzodiazepine concentrations were measured.
Fracture is considered to be the result of either an increased tendency to fall or an increased tendency to fracture, or both, so it would have been appropriate to gather information on history of fall. Use of benzodiazepines may lead to hip fracture by increasing the risk of falling and by affecting reaction time rather than by an intrinsic effect on bone. Did the authors obtain data on osteoporosis? How many patients were taking a drug prescribed because of osteoporosis?
The authors dismiss the role of dose and elimination half life.
In contrast, we reported that dose and elimination of
benzodiazepines have an independent and additive effect to increase
the risk of falls2 and hip fracture.3 In
addition, in
Read all Rapid Responses